财务老将曹冬"接棒"京东健康CEO

Group 1 - The core point of the article is the appointment of Cao Dong as the new CEO of JD Health, following the resignation of Jin Enlin for family reasons [1] - Cao Dong has been with JD since January 2012 and has held various leadership roles within the financial system of JD Group, including CFO of JD Health from April 2019 to May 2023 [1] - The board of directors of JD Health will now include Cao Dong as the executive director, along with other members such as Liu Qiangdong and independent directors [1] Group 2 - JD Health reported a revenue of 35.29 billion RMB for the first half of 2025, representing a year-on-year increase of 24.5%, with a net profit of 3.57 billion RMB, up 35% [2] - For the full year of 2024, JD Health's revenue was 59.93 billion RMB, showing a year-on-year growth of 11.55%, while the net profit attributable to shareholders was 4.16 billion RMB, increasing by 94.31% [2] - As of the report date, JD Health's stock price rose by 1.63% to 65.55 HKD, with a total market capitalization of 209.86 billion HKD [2]